In Switzerland, the median time from first submission by a pharmaceutical company to availability of a medicinal product to patients is almost 650 days.
show more articles
people work in the pharmaceutical industry in Switzerland. A further 200,000 jobs at least also depend indirectly on the sector.
is the pharmaceutical industry's share of Swiss goods exports, making it the country's most important export sector by far.
Pharmacological and technological innovations will bring about a fundamental change in the way medicines are developed and used, enabling new approaches to be adopted in research.
People in Switzerland benefit from access to high-quality healthcare provision. However, there is still a need for action and improvement in various areas.
Interpharma, the association of Switzerland’s research-based pharmaceutical industry, was founded in Basel in 1933.
Interpharma informs the public about issues that are important to the research-based pharmaceutical industry in Switzerland, including the pharma market in Switzerland, healthcare and biomedical research.
Information on our key figures and activities in the financial year 2020
More about the tasks and overriding aims of Interpharma
Latest information and media contacts for media representatives